https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-11-02 09:02:162022-11-02 09:02:16Enzyre closes Series A financing round of EUR 12M to advance pioneering diagnostic technology platform for hemophilia patients
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-27 15:30:562023-06-14 15:51:57Top takeaways from Mike Ward’s fireside chat with Werner Lanthaler, CEO of Evotec
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2022-10-25 17:14:192022-10-25 17:14:19ImaginAb Announces First Patient Dosed in Australia in Phase IIb iPREDICT Trial
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2022-10-25 10:22:492022-10-25 10:24:22Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-20 16:01:262023-06-14 15:52:19An Overview of Optimum’s 14th Annual Healthcare Investor Conference 2022
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-20 11:07:452022-10-20 11:07:45Gadeta Appoints Scientific Advisory Board and Provides Business Update
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-20 10:09:552022-10-20 10:09:55Enhanc3D Genomics raises £10 million in Series A financing to advance GenLink3D proprietary technology platform
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-20 08:03:362022-10-20 08:03:36STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-20 07:59:132022-10-20 07:59:13ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-19 14:53:462022-10-19 14:53:46AMSilk Relocate Offices to Support Expansion Plans
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-19 08:04:532022-10-19 08:25:28Neuraxpharm launches European campaign to increase awareness of medical cannabis
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-18 08:39:372022-10-18 08:39:37Synaffix Licenses CliCr® Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-17 08:41:202022-10-17 08:51:15Verona Pharma Secures Debt Financing of up to $150 Million from Oxford Finance
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-17 08:04:002022-10-17 08:04:00ImaginAb and Cyclotek Enter into Manufacturing and Distribution Agreement for CD8 ImmunoPET Agent in Australia
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-14 08:55:362022-10-14 08:55:36Verona Pharma Announces Analyses Demonstrating Ensifentrine Reduced Exacerbation Rates Across Subgroups in Phase 3 ENHANCE-2 Trial for COPD
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-11 08:07:552022-10-11 08:07:55Muna Therapeutics Awarded $4.9M Grant from The Michael J. Fox Foundation for Parkinson’s Research Supports Development of Disease Modifying Therapy for Parkinson’s Disease
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-10 09:13:322022-10-11 09:18:45Novo Nordisk Foundation establishes fellowships with four top international universities
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-10 09:12:352022-10-11 09:13:20Novo Nordisk Foundation and World Food Programme launch partnership to improve food systems in Rwanda and Uganda
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2022-10-06 09:13:582022-10-07 09:14:18Panaxia and Neuraxpharm to enter new medical cannabis markets in Europe
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2022-09-28 09:00:222022-09-29 12:38:52Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid TumorsFor more information about Optimum Strategic Communications, please get in touch.
